Telomerase in cells
Laboratory studies found increased hTERT or telomerase activity and telomere length in certain cultured human cells.
Also called Epithalon • Ala-Glu-Asp-Gly
Epitalon is a synthetic four-amino-acid peptide studied for telomerase activity, pineal signaling, and circadian rhythms. Cell findings are intriguing, while modern human evidence for sleep or longevity remains limited.
Epitalon, also spelled Epithalon, is the synthetic tetrapeptide Ala-Glu-Asp-Gly. It emerged from work on Epithalamin, a pineal-gland extract studied by Vladimir Khavinson and colleagues. The extract and the purified four-amino-acid compound are related but not interchangeable in interpreting study results.
Telomeres protect chromosome ends and generally shorten as cells divide. Telomerase can add telomeric DNA back. Epitalon increased telomerase activity and telomere length in cultured human cells, including a more recent cell-line study, but neither experiment shows that an Epitalon course lengthens telomeres or extends life in people.
Its other major research thread involves pineal signaling, melatonin rhythms, and sleep. Many community users focus on evening cycles for that reason. The human evidence is older and limited, and some frequently cited clinical findings belong to Epithalamin rather than purified Epitalon.
Laboratory studies found increased hTERT or telomerase activity and telomere length in certain cultured human cells.
Experimental work links Epitalon and related pineal preparations to melatonin and circadian pathways; direct human effects remain uncertain.
Animal and cell studies have explored antioxidant enzymes, mitochondrial responses, and stress resistance.
None of these mechanisms establishes that community SubQ cycles slow aging or correct a sleep disorder in people.
These are research targets and community observations, not established clinical benefits.
Epitalon increased telomerase activity and telomere length in cultured human cells; in-vivo human benefit remains unproven.
Older pineal-peptide studies and community reports suggest changes in sleep or melatonin rhythm, but modern Epitalon-specific trials are lacking.
Some animal studies reported improved survival measures. Those results cannot be converted into a human longevity claim.
Older clinical and animal work explored degenerative retinal disease, but evidence is too limited for a treatment conclusion.
Some animal studies reported lower tumor incidence; telomerase-related cancer implications remain unresolved.
Some users report more restful sleep and better daytime energy during a cycle, though these changes are subjective.
The community schedule is a short evening SubQ cycle. It is not an FDA-approved regimen or a modern dose-finding protocol; older milligram-heavy reports may involve Epithalamin extract rather than purified Epitalon.
Sign in or create a free account to view this content.
Wash your hands, clean the work surface, and wipe both vial stoppers with alcohol. Allow them to dry.
Use a new sterile syringe and needle to direct the selected volume of compatible diluent down the inside wall of the vial.
Swirl or roll the vial until the contents dissolve; do not shake.
Store refrigerated at 2–8°C (36–46°F) and protected from light when the product instructions support this. Record the reconstitution date in your research journal.
The combinations below are community research ideas. Their safety and additive effects have not been established in controlled human studies.
This pairs pineal and telomere interests with mitochondrial membrane research; neither compound proves an anti-aging effect in people.
MOTS-c is discussed for metabolic adaptation while Epitalon is usually tracked for sleep and circadian response. Distinct goals make attribution easier to plan, but synergy is untested.
This pairs telomere-oriented research with a metabolic cofactor. No controlled combination outcome is available.
Both come from the Khavinson peptide tradition. Pinealon focuses on neuronal stress models, while Epitalon is discussed for pineal timing and telomeres.
Formal modern safety data for purified Epitalon are limited. FDA has identified potential immunogenicity from aggregation and peptide-related impurities in compounded products.
Epitalon is one of our favorite peptides. It is rarely at the top of popularity lists, yet in our own research it was one of the fastest and most noticeable. The result we cared about was sleep: the rhythm felt more settled, and that made the next day better.
Most people come to Epitalon for the telomere story. We find that biology fascinating, but we would not claim that a short cycle lengthens human life. The near-term sleep and circadian experience is the more useful reason we keep watching it. Limited modern human data and an unfinished safety picture are what hold it at a B rather than an A.
Peptide Protocols
Send us a message and we’ll reply to the email address you provide.